Drug intelligence / Profile preview

ceramide-3

Development stage
Unknown
Lead developer
Evonik
Modality
Small Molecules
Administration
Topical
01

Overview

Ceramide 3 is a synthetic or plant-derived lipid molecule, chemically classified as an N-acylated phytosphingosine (specifically, phytosphingosine acylated with stearic acid). It is a major component of the stratum corneum in human skin and plays a critical role in maintaining and restoring the skin’s moisture barrier. By forming lipid bilayers that trap water molecules, ceramide 3 enhances hydration, repairs micro-damages to the skin barrier, and provides protection against irritants. Its hydrophilic character allows for superior water retention compared to other ceramides. It is widely used as an active ingredient in moisturizers and topical formulations for dry or sensitive skin conditions such as eczema, rosacea, and psoriasis[1][5][7]. Mechanistically, it acts by replenishing depleted natural ceramides in the epidermis to restore barrier function rather than targeting specific protein receptors.

Other names
N-(9Z-octadecenoyl)-4-hydroxysphinganineN-(9Z-octadecenoyl)phytosphingosineN-octadecanoylphytosphingosineN-oleoylphytosphingosineN-oeloeoyl–4-hydroxysphinganine

Beyond the preview

Go deeper on ceramide-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ceramide-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call